Last 12 months
Inside the activity.
0 purchase rows · 240 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 200 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 31 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 01, 2016 Filed Feb 3, 2016 18:58 UTC |
Mahony SusanSVP & Pres., Lilly Oncology
|
Exercise / conversionCommon Stock | 9,843 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-16-000302 · wf-form4_145452587491047.xml · nonDerivative · entry 1 Mahony Susan · CIK 0001463321 · SVP & Pres., Lilly Oncology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,524 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2016 Filed Feb 3, 2016 19:00 UTC |
Peterson Barton RSr. VP, Corp. Affairs & Comm.
|
Exercise / conversionRestricted Stock Unit · Derivative | 5,698 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-16-000304 · wf-form4_145452601216567.xml · derivative · entry 4 Peterson Barton R · CIK 0001466550 · Sr. VP, Corp. Affairs & Comm. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,698 shares Expires 2016-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 01, 2016 Filed Feb 3, 2016 19:00 UTC |
Peterson Barton RSr. VP, Corp. Affairs & Comm.
|
Tax withholdingCommon Stock | 2,680 | $79.10 | $211,988.00 |
DisclosureSEC source: 0000059478-16-000304 · wf-form4_145452601216567.xml · nonDerivative · entry 2 Peterson Barton R · CIK 0001466550 · Sr. VP, Corp. Affairs & Comm. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,208 Read SEC document |
| February 01, 2016 Filed Feb 3, 2016 19:00 UTC |
Peterson Barton RSr. VP, Corp. Affairs & Comm.
|
Exercise / conversionCommon Stock | 5,698 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-16-000304 · wf-form4_145452601216567.xml · nonDerivative · entry 1 Peterson Barton R · CIK 0001466550 · Sr. VP, Corp. Affairs & Comm. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,888 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2016 Filed Feb 3, 2016 19:02 UTC |
Rice Derica WEVP-Global Services and CFO
|
Exercise / conversionRestricted Stock Unit · Derivative | 19,685 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-16-000306 · wf-form4_145452613928424.xml · derivative · entry 8 Rice Derica W · CIK 0001359067 · EVP-Global Services and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 19,685 shares Expires 2016-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 01, 2016 Filed Feb 3, 2016 19:02 UTC |
Rice Derica WEVP-Global Services and CFO
|
SaleCommon Stock | 6,546 | $78.36 | $512,944.56 |
DisclosureSEC source: 0000059478-16-000306 · wf-form4_145452613928424.xml · nonDerivative · entry 3 Rice Derica W · CIK 0001359067 · EVP-Global Services and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,868 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2015. F2 · price: This transaction was executed in multiple trades at prices ranging from $78.12 to $78.63. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 01, 2016 Filed Feb 3, 2016 19:02 UTC |
Rice Derica WEVP-Global Services and CFO
|
Tax withholdingCommon Stock | 9,146 | $79.10 | $723,448.60 |
DisclosureSEC source: 0000059478-16-000306 · wf-form4_145452613928424.xml · nonDerivative · entry 2 Rice Derica W · CIK 0001359067 · EVP-Global Services and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,414 Read SEC document |
| February 01, 2016 Filed Feb 3, 2016 19:02 UTC |
Rice Derica WEVP-Global Services and CFO
|
Exercise / conversionCommon Stock | 19,685 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-16-000306 · wf-form4_145452613928424.xml · nonDerivative · entry 1 Rice Derica W · CIK 0001359067 · EVP-Global Services and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,560 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2016 Filed Feb 3, 2016 19:04 UTC |
Ricks David ASVP and Pres, Lilly Bio-Meds
|
Exercise / conversionRestricted Stock Unit · Derivative | 9,843 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-16-000308 · wf-form4_145452625935962.xml · derivative · entry 6 Ricks David A · CIK 0001538604 · SVP and Pres, Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,843 shares Expires 2016-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 01, 2016 Filed Feb 3, 2016 19:04 UTC |
Ricks David ASVP and Pres, Lilly Bio-Meds
|
SaleCommon Stock | 3,273 | $78.36 | $256,472.28 |
DisclosureSEC source: 0000059478-16-000308 · wf-form4_145452625935962.xml · nonDerivative · entry 3 Ricks David A · CIK 0001538604 · SVP and Pres, Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,863 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 9, 2015. F2 · price: This transaction was executed in multiple trades at prices ranging from $78.19 to $78.61. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 01, 2016 Filed Feb 3, 2016 19:04 UTC |
Ricks David ASVP and Pres, Lilly Bio-Meds
|
Tax withholdingCommon Stock | 4,656 | $79.10 | $368,289.60 |
DisclosureSEC source: 0000059478-16-000308 · wf-form4_145452625935962.xml · nonDerivative · entry 2 Ricks David A · CIK 0001538604 · SVP and Pres, Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,136 Read SEC document |
| February 01, 2016 Filed Feb 3, 2016 19:04 UTC |
Ricks David ASVP and Pres, Lilly Bio-Meds
|
Exercise / conversionCommon Stock | 9,843 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-16-000308 · wf-form4_145452625935962.xml · nonDerivative · entry 1 Ricks David A · CIK 0001538604 · SVP and Pres, Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,792 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2016 Filed Feb 3, 2016 19:06 UTC |
Simmons Jeffrey NSVP&Pres. Elanco Animal Health
|
Exercise / conversionRestricted Stock Unit · Derivative | 9,843 | $79.10 | $778,581.30 |
DisclosureSEC source: 0000059478-16-000310 · wf-form4_145452637957902.xml · derivative · entry 4 Simmons Jeffrey N · CIK 0001479079 · SVP&Pres. Elanco Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,843 shares Expires 2016-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 01, 2016 Filed Feb 3, 2016 19:06 UTC |
Simmons Jeffrey NSVP&Pres. Elanco Animal Health
|
Tax withholdingCommon Stock | 4,553 | $79.10 | $360,142.30 |
DisclosureSEC source: 0000059478-16-000310 · wf-form4_145452637957902.xml · nonDerivative · entry 2 Simmons Jeffrey N · CIK 0001479079 · SVP&Pres. Elanco Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,990 Read SEC document |
| February 01, 2016 Filed Feb 3, 2016 19:06 UTC |
Simmons Jeffrey NSVP&Pres. Elanco Animal Health
|
Exercise / conversionCommon Stock | 9,843 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-16-000310 · wf-form4_145452637957902.xml · nonDerivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · SVP&Pres. Elanco Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,543 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2016 Filed Feb 3, 2016 19:09 UTC |
Walsh Fionnuala MSVP, Global Quality
|
Exercise / conversionRestricted Stock Unit · Derivative | 4,144 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-16-000312 · wf-form4_145452653273206.xml · derivative · entry 6 Walsh Fionnuala M · CIK 0001524637 · SVP, Global Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,144 shares Expires 2016-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 01, 2016 Filed Feb 3, 2016 19:09 UTC |
Walsh Fionnuala MSVP, Global Quality
|
Tax withholdingCommon Stock | 1,949 | $79.10 | $154,165.90 |
DisclosureSEC source: 0000059478-16-000312 · wf-form4_145452653273206.xml · nonDerivative · entry 2 Walsh Fionnuala M · CIK 0001524637 · SVP, Global Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,645 Read SEC document |
| February 01, 2016 Filed Feb 3, 2016 19:09 UTC |
Walsh Fionnuala MSVP, Global Quality
|
Exercise / conversionCommon Stock | 4,144 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-16-000312 · wf-form4_145452653273206.xml · nonDerivative · entry 1 Walsh Fionnuala M · CIK 0001524637 · SVP, Global Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,594 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2016 Filed Feb 3, 2016 19:14 UTC |
TAI JACKSON PDirector
|
PurchaseCommon Stock | 3,170 | $78.62 | $249,225.40 |
DisclosureSEC source: 0000059478-16-000314 · wf-form4_145452683547730.xml · nonDerivative · entry 1 TAI JACKSON P · CIK 0001173275 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,487 F1 · price: This transaction was executed in multiple trades at prices ranging from $78.57 to $78.64. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 29, 2016 Filed Feb 2, 2016 20:32 UTC |
Zulueta Alfonso GSVP& Pres., Emerging Markets
|
SaleCommon Stock | 5,000 | $78.75 | $393,750.00 |
DisclosureSEC source: 0000059478-16-000281 · wf-form4_145444515531055.xml · nonDerivative · entry 1 Zulueta Alfonso G · CIK 0001596336 · SVP& Pres., Emerging Markets 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,101 Read SEC document |
| January 29, 2016 Filed Feb 2, 2016 20:35 UTC |
Alvarez RalphDirector
|
GrantCommon Stock | 119 | $83.23 | $9,904.37 |
DisclosureSEC source: 0000059478-16-000283 · wf-form4_145444532299132.xml · nonDerivative · entry 1 Alvarez Ralph · CIK 0001310215 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,671 Read SEC document |
| January 29, 2016 Filed Feb 2, 2016 20:38 UTC |
MARRAM ELLEN RDirector
|
GrantCommon Stock | 79 | $83.23 | $6,575.17 |
DisclosureSEC source: 0000059478-16-000285 · wf-form4_145444548062426.xml · nonDerivative · entry 1 MARRAM ELLEN R · CIK 0001234124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,914 Read SEC document |
| January 26, 2016 Filed Jan 28, 2016 23:40 UTC |
LECHLEITER JOHN CDirector · Chairman, President and CEO
|
GrantRestricted Stock Unit · Derivative | 46,097 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-16-000265 · wf-form4_145402440207552.xml · derivative · entry 6 LECHLEITER JOHN C · CIK 0001209281 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,097 Underlying: Common Stock · 46,097 shares Expires 2017-02-01 F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| January 26, 2016 Filed Jan 28, 2016 23:40 UTC |
LECHLEITER JOHN CDirector · Chairman, President and CEO
|
GrantCommon Stock | 83,939 | $81.96 | $6,879,640.44 |
DisclosureSEC source: 0000059478-16-000265 · wf-form4_145402440207552.xml · nonDerivative · entry 1 LECHLEITER JOHN C · CIK 0001209281 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 726,488 Read SEC document |
| January 26, 2016 Filed Jan 28, 2016 23:41 UTC |
Rice Derica WEVP-Global Services and CFO
|
GrantRestricted Stock Unit · Derivative | 19,463 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-16-000266 · wf-form4_145402447437605.xml · derivative · entry 5 Rice Derica W · CIK 0001359067 · EVP-Global Services and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,463 Underlying: Common Stock · 19,463 shares Expires 2017-02-01 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| January 26, 2016 Filed Jan 28, 2016 23:41 UTC |
Rice Derica WEVP-Global Services and CFO
|
GrantCommon Stock | 36,875 | $81.96 | $3,022,275.00 |
DisclosureSEC source: 0000059478-16-000266 · wf-form4_145402447437605.xml · nonDerivative · entry 1 Rice Derica W · CIK 0001359067 · EVP-Global Services and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,875 Read SEC document |
| January 26, 2016 Filed Jan 28, 2016 23:42 UTC |
Mahony SusanSVP & Pres., Lilly Oncology
|
GrantRestricted Stock Unit · Derivative | 9,732 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-16-000267 · wf-form4_145402454064285.xml · derivative · entry 5 Mahony Susan · CIK 0001463321 · SVP & Pres., Lilly Oncology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,732 Underlying: Common Stock · 9,732 shares Expires 2017-02-01 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| January 26, 2016 Filed Jan 28, 2016 23:42 UTC |
Mahony SusanSVP & Pres., Lilly Oncology
|
GrantCommon Stock | 1,149 | $81.96 | $94,172.04 |
DisclosureSEC source: 0000059478-16-000267 · wf-form4_145402454064285.xml · nonDerivative · entry 3 Mahony Susan · CIK 0001463321 · SVP & Pres., Lilly Oncology 10b5-1 filing: Not disclosed Ownership: Indirect · by husband Disclosed balance after: 9,533 F1 · ownership.direct: Reporting person disclaims beneficial ownership of these shares. Read SEC document |
| January 26, 2016 Filed Jan 28, 2016 23:42 UTC |
Mahony SusanSVP & Pres., Lilly Oncology
|
GrantCommon Stock | 19,093 | $81.96 | $1,564,862.28 |
DisclosureSEC source: 0000059478-16-000267 · wf-form4_145402454064285.xml · nonDerivative · entry 1 Mahony Susan · CIK 0001463321 · SVP & Pres., Lilly Oncology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,681 Read SEC document |
| January 26, 2016 Filed Jan 28, 2016 23:43 UTC |
Peterson Barton RSr. VP, Corp. Affairs & Comm.
|
GrantRestricted Stock Unit · Derivative | 5,634 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-16-000268 · wf-form4_145402462244105.xml · derivative · entry 3 Peterson Barton R · CIK 0001466550 · Sr. VP, Corp. Affairs & Comm. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,634 Underlying: Common Stock · 5,634 shares Expires 2017-02-01 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| January 26, 2016 Filed Jan 28, 2016 23:43 UTC |
Peterson Barton RSr. VP, Corp. Affairs & Comm.
|
GrantCommon Stock | 11,785 | $81.96 | $965,898.60 |
DisclosureSEC source: 0000059478-16-000268 · wf-form4_145402462244105.xml · nonDerivative · entry 1 Peterson Barton R · CIK 0001466550 · Sr. VP, Corp. Affairs & Comm. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,190 Read SEC document |
| January 26, 2016 Filed Jan 28, 2016 23:45 UTC |
Conterno Enrique ASr. VP & Pres., Lilly Diabetes
|
GrantRestricted Stock Unit · Derivative | 10,244 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-16-000269 · wf-form4_145402468774587.xml · derivative · entry 3 Conterno Enrique A · CIK 0001476151 · Sr. VP & Pres., Lilly Diabetes 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,244 Underlying: Common Stock · 10,244 shares Expires 2017-02-01 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| January 26, 2016 Filed Jan 28, 2016 23:45 UTC |
Conterno Enrique ASr. VP & Pres., Lilly Diabetes
|
GrantCommon Stock | 19,953 | $81.96 | $1,635,347.88 |
DisclosureSEC source: 0000059478-16-000269 · wf-form4_145402468774587.xml · nonDerivative · entry 1 Conterno Enrique A · CIK 0001476151 · Sr. VP & Pres., Lilly Diabetes 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,084 Read SEC document |
| January 26, 2016 Filed Jan 28, 2016 23:46 UTC |
Simmons Jeffrey NSVP&Pres. Elanco Animal Health
|
GrantRestricted Stock Unit · Derivative | 10,244 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-16-000270 · wf-form4_145402475570550.xml · derivative · entry 3 Simmons Jeffrey N · CIK 0001479079 · SVP&Pres. Elanco Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,244 Underlying: Common Stock · 10,244 shares Expires 2017-02-01 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| January 26, 2016 Filed Jan 28, 2016 23:46 UTC |
Simmons Jeffrey NSVP&Pres. Elanco Animal Health
|
GrantCommon Stock | 19,344 | $81.96 | $1,585,434.24 |
DisclosureSEC source: 0000059478-16-000270 · wf-form4_145402475570550.xml · nonDerivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · SVP&Pres. Elanco Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,700 Read SEC document |
| January 26, 2016 Filed Jan 28, 2016 23:47 UTC |
Lundberg Jan MEVP,Science&Tech and Pres. LRL
|
GrantRestricted Stock Unit · Derivative | 15,366 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-16-000271 · wf-form4_145402484078040.xml · derivative · entry 3 Lundberg Jan M · CIK 0001480120 · EVP,Science&Tech and Pres. LRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,366 Underlying: Common Stock · 15,366 shares Expires 2017-02-01 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| January 26, 2016 Filed Jan 28, 2016 23:47 UTC |
Lundberg Jan MEVP,Science&Tech and Pres. LRL
|
GrantCommon Stock | 29,081 | $81.96 | $2,383,478.76 |
DisclosureSEC source: 0000059478-16-000271 · wf-form4_145402484078040.xml · nonDerivative · entry 1 Lundberg Jan M · CIK 0001480120 · EVP,Science&Tech and Pres. LRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,501 Read SEC document |
| January 26, 2016 Filed Jan 28, 2016 23:48 UTC |
Fry Stephen FSVP, HR & Diversity
|
GrantRestricted Stock Unit · Derivative | 7,683 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-16-000272 · wf-form4_145402490311623.xml · derivative · entry 3 Fry Stephen F · CIK 0001513324 · SVP, HR & Diversity 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,683 Underlying: Common Stock · 7,683 shares Expires 2017-02-01 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| January 26, 2016 Filed Jan 28, 2016 23:48 UTC |
Fry Stephen FSVP, HR & Diversity
|
GrantCommon Stock | 14,525 | $81.96 | $1,190,469.00 |
DisclosureSEC source: 0000059478-16-000272 · wf-form4_145402490311623.xml · nonDerivative · entry 1 Fry Stephen F · CIK 0001513324 · SVP, HR & Diversity 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,215 Read SEC document |
| January 26, 2016 Filed Jan 28, 2016 23:49 UTC |
Walsh Fionnuala MSVP, Global Quality
|
GrantRestricted Stock Unit · Derivative | 4,610 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-16-000273 · wf-form4_145402498024401.xml · derivative · entry 5 Walsh Fionnuala M · CIK 0001524637 · SVP, Global Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,610 Underlying: Common Stock · 4,610 shares Expires 2017-02-01 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| January 26, 2016 Filed Jan 28, 2016 23:49 UTC |
Walsh Fionnuala MSVP, Global Quality
|
GrantCommon Stock | 7,081 | $81.96 | $580,358.76 |
DisclosureSEC source: 0000059478-16-000273 · wf-form4_145402498024401.xml · nonDerivative · entry 3 Walsh Fionnuala M · CIK 0001524637 · SVP, Global Quality 10b5-1 filing: Not disclosed Ownership: Indirect · by husband Disclosed balance after: 29,659 F1 · ownership.direct: Reporting person disclaims beneficial ownership of these shares. Read SEC document |
| January 26, 2016 Filed Jan 28, 2016 23:49 UTC |
Walsh Fionnuala MSVP, Global Quality
|
GrantCommon Stock | 9,041 | $81.96 | $741,000.36 |
DisclosureSEC source: 0000059478-16-000273 · wf-form4_145402498024401.xml · nonDerivative · entry 1 Walsh Fionnuala M · CIK 0001524637 · SVP, Global Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,450 Read SEC document |
| January 26, 2016 Filed Jan 28, 2016 23:52 UTC |
Ricks David ASVP and Pres, Lilly Bio-Meds
|
GrantRestricted Stock Unit · Derivative | 10,244 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-16-000274 · wf-form4_145402513522111.xml · derivative · entry 3 Ricks David A · CIK 0001538604 · SVP and Pres, Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,244 Underlying: Common Stock · 10,244 shares Expires 2017-02-01 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| January 26, 2016 Filed Jan 28, 2016 23:52 UTC |
Ricks David ASVP and Pres, Lilly Bio-Meds
|
GrantCommon Stock | 19,016 | $81.96 | $1,558,551.36 |
DisclosureSEC source: 0000059478-16-000274 · wf-form4_145402513522111.xml · nonDerivative · entry 1 Ricks David A · CIK 0001538604 · SVP and Pres, Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,949 Read SEC document |
| January 26, 2016 Filed Jan 28, 2016 23:53 UTC |
Crowe Maria APresident, Mfg. Operations
|
GrantRestricted Stock Unit · Derivative | 8,195 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-16-000275 · wf-form4_145402521583642.xml · derivative · entry 2 Crowe Maria A · CIK 0001538603 · President, Mfg. Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,195 Underlying: Common Stock · 8,195 shares Expires 2017-02-01 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| January 26, 2016 Filed Jan 28, 2016 23:53 UTC |
Crowe Maria APresident, Mfg. Operations
|
GrantCommon Stock | 14,872 | $81.96 | $1,218,909.12 |
DisclosureSEC source: 0000059478-16-000275 · wf-form4_145402521583642.xml · nonDerivative · entry 1 Crowe Maria A · CIK 0001538603 · President, Mfg. Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,559 Read SEC document |
| January 26, 2016 Filed Jan 28, 2016 23:55 UTC |
Barnes Melissa SChief Eth/Cmpl Ofcr & SVP, ERM
|
GrantRestricted Stock Unit · Derivative | 3,073 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-16-000276 · wf-form4_145402530169593.xml · derivative · entry 3 Barnes Melissa S · CIK 0001566364 · Chief Eth/Cmpl Ofcr & SVP, ERM 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,073 Underlying: Common Stock · 3,073 shares Expires 2017-02-01 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| January 26, 2016 Filed Jan 28, 2016 23:55 UTC |
Barnes Melissa SChief Eth/Cmpl Ofcr & SVP, ERM
|
GrantCommon Stock | 4,662 | $81.96 | $382,097.52 |
DisclosureSEC source: 0000059478-16-000276 · wf-form4_145402530169593.xml · nonDerivative · entry 1 Barnes Melissa S · CIK 0001566364 · Chief Eth/Cmpl Ofcr & SVP, ERM 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,286 Read SEC document |
| January 26, 2016 Filed Jan 28, 2016 23:56 UTC |
Harrington Michael JSenior VP and General Counsel
|
GrantRestricted Stock Unit · Derivative | 9,732 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-16-000277 · wf-form4_145402537230894.xml · derivative · entry 3 Harrington Michael J · CIK 0001566340 · Senior VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,732 Underlying: Common Stock · 9,732 shares Expires 2017-02-01 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| January 26, 2016 Filed Jan 28, 2016 23:56 UTC |
Harrington Michael JSenior VP and General Counsel
|
GrantCommon Stock | 17,961 | $81.96 | $1,472,083.56 |
DisclosureSEC source: 0000059478-16-000277 · wf-form4_145402537230894.xml · nonDerivative · entry 1 Harrington Michael J · CIK 0001566340 · Senior VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,043 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.